Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Research & Development: ₫ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Research & Development?

Pharmedic Pharmaceutical Medicinal Joint Stock Company HSTC:PMC Research & Development is ₫ Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Pharmedic Pharmaceutical Medicinal Joint Stock Company's Research & Development for the three months ended in . 20 was ₫0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Research & Development Related Terms

Pharmedic Pharmaceutical Medicinal Joint Stock Company Research & Development Historical Data

* Premium members only.

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Research & Development Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Research & Development

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Research & Development

Pharmedic Pharmaceutical Medicinal Joint Stock Company Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₫ Mil mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a Research & Development of ₫ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's Research & Development too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Research & Development is ₫ Mil.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's Research & Development compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's Research & Development of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Research & Development is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current Research & Development of ₫ Mil. The current Research & Development is ₫ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current Research & Development is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Business Description

Address 367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, cosmetics, medical supplies, and other products in the health sector. The company's products include Farzincol Bottle, Farzincol Syrup, Sibemag, Vitamin C 50, Vitamin PP 500, Vitamin PP 50, Nacofar, Cooldrop, Inhaler, Povidine 10% 90ml, Povidine 4% 500, Povidine 10% 8ml, and Povidine 4% 800.